Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Acoustic neuroma screening
Introduction
Overview
Overview
According to the U.S. Preventive Services Task Force (USPTF), screening for acoustic neuroma is not recommended. Evaluation for NF-2 should be done in individuals with an apparently sporadic vestibular schwannoma occurring before the age of 30, or a spinal tumor or meningioma occurring at less than 20 years of age.
Screening
Screening
- According to U.S. Preventive Services Task Force (USPTF), screening for acoustic neuroma is not recommended.
- Annual hearing screening with BAER (Brain stem auditory evoked response test), with referral to an audiologist for amplification, or speech therapy is recommended in patients with NF-2.
- Evaluation for NF-2 should be done in individuals with an apparently sporadic vestibular schwannoma occurring before the age of 30, or a spinal tumor or meningioma occurring at less than 20 years of age.[1][2]
References
References
- ↑ Evans DG, Ramsden RT, Gokhale C, Bowers N, Huson SM, Wallace A (2007). “Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?”. Clin Genet. 71 (4): 354–8. doi:10.1111/j.1399-0004.2007.00778.x. PMID 17470137.
- ↑ D. Gareth R. Evans (2009). “Neurofibromatosis type 2 (NF2): a clinical and molecular review”. Orphanet journal of rare diseases. 4: 16. doi:10.1186/1750-1172-4-16. PMID 19545378. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Mohsen Basiri M.D.